Clinical utility of viral load measurements in individuals with chronic hepatitis C infection on antiviral therapy

This publication has 13 references indexed in Scilit:

• Prognostic factors and early predictability of sustained viral response with peginterferon alfa-2a (40KD)
  Journal of Hepatology, 2002
• Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection
  New England Journal of Medicine, 2002
• Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
  Published by Elsevier ,2001
• Peginterferon Alfa-2a in Patients with Chronic Hepatitis C
  New England Journal of Medicine, 2000
• Is an “à la carte” combination interferon alfa-2b plus ribavirin regimen possible for the first line treatment in patients with chronic hepatitis C?
  Hepatology, 2000
• Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis C
  New England Journal of Medicine, 1998
• Interferon Alfa-2b Alone or in Combination with Ribavirin for the Treatment of Relapse of Chronic Hepatitis C
  New England Journal of Medicine, 1998
• Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
  Published by Elsevier ,1998
• Prediction of response during interferon alfa 2b therapy in chronic hepatitis C patients using viral and biochemical characteristics: A comparison
  Hepatology, 1997
• Treatment of Chronic Hepatitis C with Recombinant Interferon Alfa
  New England Journal of Medicine, 1989